Healthcare provider profile · identity verified

Sean M Epps, PAC

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant · ROCKY MOUNT, NC · NPI 1184625303

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Sean M Epps, PAC received $153.15 in general payments during 2025 across 3 reported records.

Axsome Therapeutics, Inc. accounted for 78.6% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BEVESPI AEROSPHERE as an associated drug or biological on 763 records involving 473 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Bevespi Aerosphere by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Brilinta by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 43 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Lokelma by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 84 claims for Symbicort by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$153.15

3 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Axsome Therapeutics, Inc.	Unresolved — no canonical attribution shown	$120.41	78.6%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$32.74	21.4%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$153.15	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Auvelity Normalized: auvelity	Drug	Axsome Therapeutics, Inc.	$120.41	1	2025
Source payment records 2025-09-04 · Axsome Therapeutics, Inc. · $120.41 · Open Payments source
FARXIGA Normalized: farxiga	Drug	AstraZeneca Pharmaceuticals LP	$18.33	1	2025
Source payment records 2025-07-22 · AstraZeneca Pharmaceuticals LP · $18.33 · Open Payments source
BREZTRI Normalized: breztri	Drug	AstraZeneca Pharmaceuticals LP	$14.41	1	2025
Source payment records 2025-05-02 · AstraZeneca Pharmaceuticals LP · $14.41 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
FARXIGA farxiga	2025	Farxiga	2024	43 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BEVESPI AEROSPHERE open payments reported associated product	CMS Open Payments — General Payments 763 supporting records · 473 recipient NPIs · example record 1206131384	Bevespi Aerosphere · 2024 Exact normalized brand match · 1 Part D row	16	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BRILINTA open payments reported associated product	CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430	Brilinta · 2024 Exact normalized brand match · 1 Part D row	19	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	43	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	LOKELMA open payments reported associated product	CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624	Lokelma · 2024 Exact normalized brand match · 1 Part D row	25	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	84	16

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	618	166
Amlodipine Besylate	Amlodipine Besylate	457	132
Rosuvastatin Calcium	Rosuvastatin Calcium	454	114
Furosemide	Furosemide	410	133
Gabapentin	Gabapentin	399	120
Lisinopril	Lisinopril	379	102
Metoprolol Succinate	Metoprolol Succinate	372	94
Levothyroxine Sodium	Levothyroxine Sodium	361	94
Pantoprazole Sodium	Pantoprazole Sodium	344	98
Omeprazole	Omeprazole	329	87
Hydrochlorothiazide	Hydrochlorothiazide	306	87
Trazodone Hcl	Trazodone Hcl	274	66
Potassium Chloride	Potassium Chloride	249	59
Albuterol Sulfate Hfa	Albuterol Sulfate	237	89
Losartan Potassium	Losartan Potassium	236	59
Meloxicam	Meloxicam	220	56
Metformin Hcl	Metformin Hcl	216	63
Metoprolol Tartrate	Metoprolol Tartrate	216	51
Sertraline Hcl	Sertraline Hcl	213	46
Alprazolam	Alprazolam	172	34
Tamsulosin Hcl	Tamsulosin Hcl	172	47
Eliquis	Apixaban	169	42
Fluticasone Propionate	Fluticasone Propionate	165	62
Famotidine	Famotidine	150	42
Allopurinol	Allopurinol	146	36
Simvastatin	Simvastatin	146	41
Clopidogrel	Clopidogrel Bisulfate	139	39
Tramadol Hcl	Tramadol Hcl	138	43
Rybelsus	Semaglutide	134	19
Montelukast Sodium	Montelukast Sodium	130	34
Carvedilol	Carvedilol	126	34
Buspirone Hcl	Buspirone Hcl	125	30
Zolpidem Tartrate	Zolpidem Tartrate	116	16
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	114	24
Jardiance	Empagliflozin	114	21
Prednisone	Prednisone	114	65
Ezetimibe	Ezetimibe	110	18
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	105	43
Diclofenac Sodium	Diclofenac Sodium	104	29
Pravastatin Sodium	Pravastatin Sodium	104	32
Hydralazine Hcl	Hydralazine Hcl	103	32
Amitriptyline Hcl	Amitriptyline Hcl	100	22
Valsartan	Valsartan	96	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	92	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	91	22
Trulicity	Dulaglutide	90	19
Baclofen	Baclofen	89	38
Symbicort	Budesonide/Formoterol Fumarate	84	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	84	14
Citalopram Hbr	Citalopram Hydrobromide	83	18
Clonidine Hcl	Clonidine Hcl	83	21
Pregabalin	Pregabalin	83	22
Duloxetine Hcl	Duloxetine Hcl	81	19
Glipizide	Glipizide	81	26
Azithromycin	Azithromycin	79	67
Irbesartan	Irbesartan	78	18
Spironolactone	Spironolactone	77	22
Ventolin Hfa	Albuterol Sulfate	77	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	76	11
Mirtazapine	Mirtazapine	75	21
Venlafaxine Hcl Er	Venlafaxine Hcl	75	15
Atenolol	Atenolol	74	19
Linzess	Linaclotide	74	23
Promethazine Hcl	Promethazine Hcl	74	14
Celecoxib	Celecoxib	73	17
Bisoprolol Fumarate	Bisoprolol Fumarate	71	17
Hydroxyzine Hcl	Hydroxyzine Hcl	71	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	21
Metformin Hcl Er	Metformin Hcl	69	24
Lorazepam	Lorazepam	67	13
Cephalexin	Cephalexin	66	57
Glipizide Er	Glipizide	65	18
Breo Ellipta	Fluticasone/Vilanterol	64	12
Alendronate Sodium	Alendronate Sodium	63	18
Colchicine	Colchicine	63	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	24
Lovastatin	Lovastatin	63	18
Ozempic	Semaglutide	63	18
Januvia	Sitagliptin Phosphate	62	12
Doxepin Hcl	Doxepin Hcl	60	17
Escitalopram Oxalate	Escitalopram Oxalate	60	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	58	17
Diazepam	Diazepam	58	12
Clonazepam	Clonazepam	56	16
Levetiracetam	Levetiracetam	56	16
Ibuprofen	Ibuprofen	55	20
Doxazosin Mesylate	Doxazosin Mesylate	54	14
Donepezil Hcl	Donepezil Hcl	53	19
Lactulose	Lactulose	53	35
Bupropion Hcl Sr	Bupropion Hcl	52	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	11
Memantine Hcl	Memantine Hcl	52	13
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	52	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	51	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	12
Valacyclovir	Valacyclovir Hcl	51	12
Sucralfate	Sucralfate	50	18
Tresiba Flextouch U-100	Insulin Degludec	49	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	47	13
Esomeprazole Magnesium	Esomeprazole Magnesium	47	13
Paroxetine Hcl	Paroxetine Hcl	47	12
Farxiga	Dapagliflozin Propanediol	43	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	43	11
Olmesartan Medoxomil	Olmesartan Medoxomil	41	12
Methylprednisolone	Methylprednisolone	40	38
Meclizine Hcl	Meclizine Hcl	38	20
Nystatin	Nystatin	38	15
Benazepril Hcl	Benazepril Hcl	37	11
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	13
Divalproex Sodium	Divalproex Sodium	34	suppressed
Finasteride	Finasteride	33	suppressed
Primidone	Primidone	33	suppressed
Ramipril	Ramipril	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	32	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	31	suppressed
Spiriva Handihaler	Tiotropium Bromide	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Cilostazol	Cilostazol	29	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	29	suppressed
Telmisartan	Telmisartan	29	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Acyclovir	Acyclovir	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Nitroglycerin	Nitroglycerin	27	16
Tradjenta	Linagliptin	27	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	20
Hydrocortisone	Hydrocortisone	25	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	22
Fluconazole	Fluconazole	24	19
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	14
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	11
Ranolazine Er	Ranolazine	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Methimazole	Methimazole	22	suppressed
Pen Needles	Pen Needle, Diabetic	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Megestrol Acetate	Megestrol Acetate	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	20	suppressed
Estradiol	Estradiol	20	suppressed
Febuxostat	Febuxostat	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Brilinta	Ticagrelor	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Phenobarbital	Phenobarbital	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Topiramate	Topiramate	17	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	16	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Calcitriol	Calcitriol	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Indomethacin	Indomethacin	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Victoza 2-Pak	Liraglutide	15	suppressed
Lidocaine	Lidocaine	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Metolazone	Metolazone	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Xifaxan	Rifaximin	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Clotrimazole	Clotrimazole	13	suppressed
Digoxin	Digoxin	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Ibu	Ibuprofen	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Naproxen	Naproxen	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Repatha Sureclick	Evolocumab	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Veltassa	Patiromer Calcium Sorbitex	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$153.15 · 3 records	Axsome Therapeutics, Inc.	Auvelity, BREZTRI, FARXIGA	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Farxiga play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error